Serum ADAM metallopeptidase domain 12 as a promising diagnostic biomarker for breast and liver cancer.

Hanchu WangHuan WuYue Chen

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2022)

Serum ADAM12 expression showed high degree of tumor heterogeneity, and may be a valuable noninvasive diagnostic and prognostic biomarker for breast and liver cancer.

Keyphrases

poor prognosis
single cell